lymphokine-activated killer cell therapy

Known as: LAK cell therapy, cell therapy, lymphokine-activated killer, therapy, lymphokine-activated killer cell 
The use of lymphokine-activated killer cells in the treatment of any disease or disorder.

Topic mentions per year

Topic mentions per year

1986-2011
024619862011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
We describe the case of a patient with terminal adenocarcinoma of the lung with no response to lymphokine-activated killer (LAK… (More)
  • figure 1
Is this relevant?
2009
2009
Despite recent advances, median survival for patients with resectable glioblastoma multiforme (GBM) is only 12 to 15 months. We… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1997
1997
Lymphoreticular malignancies, collectively called posttransplant lymphoproliferative disorders (PTLD), eventually develop in 2-5… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
1997
1997
B CELL lymphomas which often contain the EpsteinBarr virus (EBY) make up the preponderance of tumors that collectively have been… (More)
Is this relevant?
1991
1991
We conducted a phase II study utilizing interleukin-2 (IL-2) with lymphokine-activated killer (LAK) cells as therapy for non… (More)
Is this relevant?
1990
1990
A case of unusual cholecystitis that developed on completion of interleukin-2 and lymphokine-activated killer cell therapy is… (More)
Is this relevant?
1990
1990
Fifty patients with advanced melanoma received high-dose bolus and continuous infusion interleukin-2 (IL-2) with lymphokine… (More)
Is this relevant?
1990
1990
Several groups have described the efficacy of interleukin 2 (IL-2) plus lymphokine-activated killer (LAK) cells in the treatment… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
1987
1987
Patients with advanced metastatic cancer were given combined autologous lymphokine activated killer (LAK) cell and recombinant… (More)
Is this relevant?
Highly Cited
1986
Highly Cited
1986
The adoptive transfer of tumor-infiltrating lymphocytes (TIL) expanded in interleukin-2 (IL-2) to mice bearing micrometastases… (More)
Is this relevant?